Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1647
This examiner grants 60% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17923872 | METHODS FOR TREATING INFLAMMATORY AND AUTOIMMUNE DISORDERS | Non-Final OA | President and Fellows of Harvard College |
| 17821665 | METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST | Non-Final OA | REGENERON PHARMACEUTICALS, INC. |
| 17767857 | ONCOLYTIC VIRUS COMPRISING IMMUNOMODULATORY TRANSGENES AND USES THEREOF | Final Rejection | Arizona Board of Regents on Behalf of Arizona State University |
| 18255808 | APPLICATION OF NKG2D CAR-IMMUNOCYTE IN TREATMENT OF ANTI-AGING AND AGE-RELATED DISEASES | Non-Final OA | WEST CHINA HOSPITAL, SICHUAN UNIVERSITY |
| 18053325 | BISPECIFIC ANTIBODIES THAT BIND TO B7H3 AND NKG2D | Non-Final OA | Xencor, Inc. |
| 18052131 | IMMUNOSILENCING Fc VARIANTS | Final Rejection | VISTERRA, INC. |
| 18323577 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS | Non-Final OA | Immatics Biotechnologies GmbH |
| 18314878 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS | Non-Final OA | Immatics Biotechnologies GmbH |
| 18173052 | METHODS FOR QUANTIFYING POTENCY OF REGENERATIVE IMMUNOTHERAPIES | Non-Final OA | CREATIVE MEDICAL TECHNOLOGIES, INC. |
| 18312144 | METHODS FOR IMPROVING T CELL EFFICACY | Non-Final OA | IMMATICS US, INC. |
| 18073663 | COMPOSITIONS AND METHODS FOR TREATING AND SUPPRESSING ALLERGIC RESPONSES | Non-Final OA | IgGenix, Inc. |
| 18011605 | MATERIALS AND METHODS OF TREATING CANCER | Non-Final OA | MONOPTEROS THERAPEUTICS, INC. |
| 17932057 | CLEAVABLE LINKERS | Non-Final OA | Xilio Development, Inc. |
| 17800405 | NON-PROTEIN A PURIFICATION METHOD FOR ADALIMUMAB | Final Rejection | PRESTIGE BIOPHARMA PTE LTD. |
| 17777828 | METHODS FOR PROVIDING CONTINUOUS THERAPY AGAINST PNAG COMPRISING MICROBES | Final Rejection | ALOPEXX, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy